← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CSPC OUYI · Approved 2005-03-23

Drug application

FDA Application #

ANDA075477

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

GABAPENTIN

Active ingredients

GABAPENTIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

CSPC OUYI

Manufacturer

Westminster Pharmaceuticals, LLC

First approval

2005-03-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown